Use of gastroscopy in the management of pediatric toxic ingestions: insights from a decade of experience – a retrospective study
Year: 2026
Type: article
Study design: Observational Study
Abstract: Objective: Pediatric poisonings account for a significant proportion of poison center consultations. Gastrointestinal decontamination (GD) is a crucial intervention in cases of acute poisoning, yet its effectiveness remains debated. This study aims to evaluate the role of esophagogastroduodenoscopy (EGD) in pediatric GD by retrospectively analyzing cases of suspected or confirmed toxic ingestions in which EGD was employed as a decontamination technique. Methods: A retrospective review was conducted on medical records from our hospital between 1 January 2015, and 31 March 2025. Pediatric patients (<18 years) who underwent EGD for GD following suspected or confirmed ingestion of toxic drugs were included. Results: A total of 19 cases met the inclusion criteria. In all cases, a potentially toxic drug dose was ingested. EGD was primarily indicated in the presence of sustained-release (SR) formulations, delayed gastric emptying, or severe clinical presentation. In 15 cases, xenobiotic residues (pharmacobezoars, intact tablets, or gastric contents containing drug material) were successfully removed via EGD. No complications were reported, and all patients had favorable outcomes. Conclusion: EGD appears to be an effective GD technique in selected pediatric poisoning cases, particularly those involving bezoar-forming drugs, SR formulations, and substances that impair gastrointestinal motility. It may also be useful in cases of massive ingestion of potentially harmful substances. Further research is needed to establish standardized guidelines for its use in pediatric toxicology.
Source: Frontiers in Toxicology
Authors: Marco Marano, Lavinia Di Meglio, Mara Pisani, Bianca Maria Goffredo, Carla Olita, Simona Faraci, Francesca Rea, Salvatore Perdichizzi, Giorgio Zampini, Piero David, Filippo Torroni
Language: English
Subfield: Emergency Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,077
Funder: Ministero della Salute
OpenAlex ID: W7128635931
